Moreover, the prognostic significance of ASAP2 should be validated with HCC patients with different etiological backgrounds, such as Hepatits C (HCV) and nonalcoholic steatohepatitis (NASH). This evidence concerns the gene ASAP2 and hepatocellular carcinoma.